Nome | Settore | Analyst Name | Analyst Job Title | Rating Quantitativo | Data | |
---|---|---|---|---|---|---|
Sartorius AG Vorz-Inhaber-Akt ohne Stimmrecht | Salute | Jay Lee | Senior Equity Analyst | 19/04/2024 | ||
Sartorius Stedim Biotech SA | Salute | Jay Lee | Senior Equity Analyst | 19/04/2024 | ||
Intuitive Surgical Inc | Salute | Alex Morozov | Regional Director | 19/04/2024 | ||
Elevance Health Inc | Salute | Julie Utterback | Senior Equity Analyst | 18/04/2024 | ||
Abbott Laboratories | Salute | Debbie Wang | Senior Equity Analyst | 17/04/2024 | ||
Eli Lilly and Co | Salute | Damien Conover | Sector Director | 17/04/2024 | ||
Johnson & Johnson | Salute | Damien Conover | Sector Director | 16/04/2024 | ||
UnitedHealth Group Inc | Salute | Julie Utterback | Senior Equity Analyst | 16/04/2024 | ||
CRISPR Therapeutics AG | Salute | Rachel Elfman | Equity Analyst | 12/04/2024 | ||
Curaleaf Holdings Inc | Salute | Kristoffer Inton | Strategist | 12/04/2024 | ||
GSK PLC | Salute | Damien Conover | Sector Director | 11/04/2024 | ||
GSK PLC ADR | Salute | Damien Conover | Sector Director | 11/04/2024 | ||
Vertex Pharmaceuticals Inc | Salute | Rachel Elfman | Equity Analyst | 11/04/2024 | ||
China Resources Pharmaceutical Group Ltd Registered Shs Unitary 144A/Reg S | Salute | Yurou Zheng | Equity Analyst | 11/04/2024 | ||
Carl Zeiss Meditec AG | Salute | Keonhee Kim | Equity Analyst | 11/04/2024 | ||
Shanghai Pharmaceuticals Holding Co Ltd Class H | Salute | Yurou Zheng | Equity Analyst | 11/04/2024 | ||
AVITA Medical Inc | Salute | Shane Ponraj | Equity Analyst | 11/04/2024 | ||
Merck KGaA | Salute | Julie Utterback | Senior Equity Analyst | 10/04/2024 | ||
Merck KGaA ADR | Salute | Julie Utterback | Senior Equity Analyst | 10/04/2024 | ||
Tilray Brands Inc | Salute | Kristoffer Inton | Strategist | 09/04/2024 |